Exosomal microRNA-23a-3p contributes to the progression of cholangiocarcinoma by interaction with Dynamin3

References

• Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145(6):1215–1229.
   PubMed Web of Science ®Google Scholar
• Dewdney A, Chau I. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. Adv Oncol. 2010;5:31–32.
   Google Scholar
• Isomoto H. Epigenetic alterations associated with cholangiocarcinoma (review). Oncol Rep. 2009;22(2):227–232.
   PubMed Web of Science ®Google Scholar
• Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol. 2007;23(1):175.
   PubMed Web of Science ®Google Scholar
• Huang S, He X, Ding J, et al. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer. 2008;123(4):972–978.
   PubMed Web of Science ®Google Scholar
• Lu S, Xu Q. MicroRNA-23a inhibits melanoma cell proliferation, migration, and invasion in mice through a negative feedback regulation of sdcbp and the MAPK/ERK signaling pathway. IUBMB Life. 2019;71(5):587–600.
   PubMed Web of Science ®Google Scholar
• Ju C, Zhou R, Sun J, et al. LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axis. Cancer Cell Int. 2018;18(1):141.
   PubMed Web of Science ®Google Scholar
• Wang X, Gao X, Tian J, et al. LINC00261 inhibits progression of pancreatic cancer by down-regulating miR-23a-3p. Arch Biochem Biophys. 2020;689:108469.
   PubMed Web of Science ®Google Scholar
• Polytarchou C, Oikonomopoulos A, Mahurkar S, et al. Assessment of circulating MicroRNAs for the diagnosis and disease activity evaluation in patients with ulcerative colitis by using the nanostring technology. Inflamm Bowel Dis. 2015;21:2533–2539.
   PubMed Web of Science ®Google Scholar
• Xiang Y, Yang Y, Lin C, et al. MiR-23a-3p promoted G1/S cell cycle transition by targeting protocadherin17 in hepatocellular carcinoma. J Physiol Biochem. 2020;76:123–134.
   PubMed Web of Science ®Google Scholar
• Kang L, Yang C, Song Y, et al. MicroRNA-23a-3p promotes the development of osteoarthritis by directly targeting SMAD3 in chondrocytes. Biochem Biophys Res Commun. 2016;478:467–473.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Chen H, Su M, et al. MicroRNA-23a-3p influences the molecular mechanism of gastric cancer cells via CCL22/PI3K/Akt axis. Bioengineered. 2021;12:11277–11287.
   PubMed Web of Science ®Google Scholar
• Fan L, Cao X, Lei Y. MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway. Bioengineered. 2021;12:12568–12582.
   PubMed Web of Science ®Google Scholar
• Niel GV, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213-228.
   PubMed Web of Science ®Google Scholar
• Wang G, Liu W, Zou Y, et al. Three isoforms of exosomal circPTGR1 promote hepatocellular carcinoma metastasis via the miR449a/MET pathway. EBioMedicine. 2019;40:432-445.
   Google Scholar
• Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569–579.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang X, Du L, et al. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Mol Cancer. 2019;18:43.
   Web of Science ®Google Scholar
• Inokawa Y, Nomoto S, Hishida M, et al. Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis. Onco Targets Ther. 2013;6:1417–1424.
   PubMed Web of Science ®Google Scholar
• Tian M, Yang X, Li Y, et al. The expression of Dynamin 1, 2, and 3 in human hepatocellular carcinoma and patient prognosis. Med Sci Monit. 2020;26:e923359.
   PubMed Web of Science ®Google Scholar
• Yang JK, Yang JP, Tong J, et al. Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma. J Neurooncol. 2017;131:255–265.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen C, Guo W, et al. DNM3 attenuates hepatocellular carcinoma growth by activating P53. Med Sci Monit. 2016;22:197–205.
   PubMed Web of Science ®Google Scholar
• Milane L, Singh A, Mattheolabakis G, et al. Exosome mediated communication within the tumor microenvironment. J Control Release. 2015;219:278–294.
   PubMed Web of Science ®Google Scholar
• Uziel O, Gutkin A, Beery E, et al. Exosomes as mediators of intercellular communication: the cancer and telomerase connection. Harefuah. 2017;156:710–714.
   PubMedGoogle Scholar
• Fang T, Lv H, Lv G, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat Commun. 2018;9:191.
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang X, Du L, et al. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Mol Cancer. 2019;18:43.
   PubMed Web of Science ®Google Scholar
• Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13:261–280.
   PubMed Web of Science ®Google Scholar
• Zhou MH, Zhou HW, Liu M, et al. The role of miR-92b in cholangiocarcinoma patients. Int J Biol Markers. 2018;33:293–300.
   PubMed Web of Science ®Google Scholar
• Likhitrattanapisal S, Kumkate S, Ajawatanawong P, et al. Dysregulation of microRNA in cholangiocarcinoma identified through a meta-analysis of microRNA profiling. World J Gastroenterol. 2020;26:4356–4371.
   PubMed Web of Science ®Google Scholar
• Pan X, Wang G, Wang B. MicroRNA-1182 and let-7a exert synergistic inhibition on invasion, migration and autophagy of cholangiocarcinoma cells through down-regulation of NUAK1. Cancer Cell Int. 2021;21:161.
   PubMed Web of Science ®Google Scholar
• Rashed MH, Bayraktar E, Helal GK, et al. Exosomes: from garbage bins to promising therapeutic targets. Int J Mol Sci. 2017;18:538.
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Kang M-H, Jeyaraj M, et al. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. 2019;8:307.
   PubMed Web of Science ®Google Scholar
• Kang J-S. Chapter 20 - The potential of exosomes as theragnostics in various clinical situations. In: Edelstein L, Smythies J, Quesenberry P, et al, editors. Exosomes. Academic Press, Amsterdam, Netherlands; 2020. p. 467–486.
   Google Scholar